• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YUE Xiaohong, YE Jiqing, SUN Liping. Biological functions and related diseases of STATs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 404-411. DOI: 10.11665/j.issn.1000-5048.20160404
Citation: YUE Xiaohong, YE Jiqing, SUN Liping. Biological functions and related diseases of STATs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 404-411. DOI: 10.11665/j.issn.1000-5048.20160404
shu

Biological functions and related diseases of STATs

More Information
    Graphical Abstract
    • Abstract
  • The signal transducer and activator of transcription(STAT)proteins, which can transmit signals from extracellular to nucleus, play important roles in biological processes. The abnormal activation of STAT3 signaling pathway usually results in many malignant diseases such as tumors(leukemias, lymphomas, breast cancer and lung cancer), inflammation or immune and rheumatoid arthritis. Numerous studies have demonstrated that the activation of STAT3, which means the phosphorylation of the residue 705, can inhibit apoptosis, induce cell proliferation and angiogenesis and finally lead to malignant diseases mentioned above. In this review, the biological functions of STAT family proteins and the related diseases of STAT3 are introduced, and the inhibitors of STAT3 are summarized simply. Further development of STATs is also proposed.
    • FullText(HTML)
    • References (61)
  • [1]
    Zhang DY, Wu JQ, Wu XM. Advances in research on STAT3 inhibitors and their anti-tumor activity[J].Prog Pharm Sci(药学进展),2012,36(7):289-298.
    [2]
    Miklossy G, Hilliard TS, Turkson J. Therapeutic modulators of STAT signalling for human diseases[J].Nat Rev Drug Discov,2013,12(8):611-629.
    [3]
    Xu XM.Novel Strategy for Virtual Screening Small Molecule Inhibitors Targeting to STAT3(以STAT3为靶点的小分子抑制剂虚拟筛选新策略)[D].Lanzhou Univerfsity,2010.
    [4]
    Siveen KS,Sikka S,Surana R,et al.Targeting the STAT3 signaling pathway in cancer:role of synthetic and natural inhibitors[J].Biochim Biophys Acta,2014,1845(2):136-154.
    [5]
    Adamkova L, Souckova K, Kovarik J. Transcription protein STAT1:biology and relation to cancer[J].Folia Biol,2007,53(1):1-6.
    [6]
    Gamero AM,Young MR,Mentor-Marcel R,et al.STAT2 contributes to promotion of colorectal and skin carcinogenesis[J].Cancer Prev Res,2010,3(4):495-504.
    [7]
    Subramaniam A,Shanmugam MK,Perumal E,et al.Potential role of signal transducer and activator of transcription(STAT)3 signaling pathway in inflammation,survival,proliferation and invasion of hepatocellular carcinoma[J].Biochimt Biophy Acta,2013,1835(1):46-60.
    [8]
    Bowman T,Garcia R,Turkson J,et al.STATs in oncogenesis[J].Oncogene,2000, 19(21):2474-2488.
    [9]
    Jing N,Tweardy DJ.Targeting Stat3 in cancer therapy[J].Anti-cancer Drugs,2005,16(6):601-607.
    [10]
    Turkson J.STAT proteins as novel targets for cancer drug discovery[J].Expert Opin Ther Targets,2004,8(5):409-422.
    [11]
    Yue P,Turkson J.Targeting STAT3 in cancer:how successful are we[J]?Expert Opin Investig Drugs,2009,18(1):45-56.
    [12]
    Debnath B,Xu SL,Neamati N.Small molecule inhibitors of signal transducer and activator of transcription 3(Stat3)protein[J].J Med Chem,2012,55(15):6645-6668.
    [13]
    Lovett-Racke AE,Yang Y,Racke MK.Th1 versus Th17:are T cell cytokines relevant in multiple sclerosis[J] ?Biochim Biophys Acta,2011,1812(2):246-251.
    [14]
    Menke J,Tillmann B,Birte K,et al.Targeting transcription factor Stat4 uncovers a role for interleukin18 in the pathogenesis of severe lupus nephritis in mice[J].Kidney Int,2011,79(4):452-463.
    [15]
    Lin JX,Leonard WJ.The role of Stat5a and Stat5b in signaling by IL2 family cytokines[J].Oncogene,2000,19(21):2566-2576.
    [16]
    Nelson EA,Walker SR,Weisberg E,et al.The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors[J].Blood,2011,117(12):3421-3429.
    [17]
    Nelson EA, Sharma SV, Settleman J, et al. A chemical biology approach to developing STAT inhibitors:molecular strategies for accelerating clinical translation[J].Oncotarget,2011,2(6):518-524.
    [18]
    Sehra S,Yao Y,Howell MD,et al.IL4 regulates skin homeostasis and the predisposition toward allergic skin inflammation[J].J Immunol,2010,184(6):3186-3190.
    [19]
    Chapoval SP,Preeta D,Smith EP,et al.STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease[J].J Immunol,2011,186(4):2571-2583.
    [20]
    Chiba Y,Nakazawa S,Todoroki M,et al.Interleukin13 augments bronchial smooth muscle contractility with an upregulation of RhoA protein[J].Am J Respir Cell Mol Biol,2009,40(2):159-167.
    [21]
    Alvarez JV, Febbo PG, Ramaswamy S, et al. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors[J].Cancer Res,2005,65(12):5054-5062.
    [22]
    Marotta LL,Almendro V,Marusyk A,et al.The JAK2/STAT3 signaling pathway is required for growth of CD44+ CD24- stem cell-like breast cancer cells in human tumors[J].J Clin Invest,2011,121(7):2723-2735.
    [23]
    Kritikou EA,Sharkey A,Abell K,et al.A dual,non-redundant,role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland[J].Development,2003,130(15):3459-3468.
    [24]
    Lieblein JC,Ball S,Hutzen B,et al.STAT3 can be activated through paracrine signaling in breast epithelial cells[J].BMC Cancer,2008,8:302.
    [25]
    Yeh YT,Ou-Yang F,Chen IF,et al.STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma[J].Int J Cancer,2006,118(12):2943-2947.
    [26]
    Walker SR,Xiang M,Frank DA.Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer[J].Mol Cell Endocrinol,2014,382(1):616-621.
    [27]
    Miklossy G,Youn UJ,Yue P,et al.Hirsutinolide series inhibit Stat3 activity,alter GCN1,MAP1B,Hsp105,G6PD,vimentin,TrxR1,and importin α-2 expression,and induce antitumor effects against human glioma[J].J Med Chem,2015,58(19):7734-7748.
    [28]
    Sun SH.Expression and significance of GRIM-19 and STAT3 in human glioma(GRIM-19和STAT3基因在脑胶质瘤中的表达及意义)[D].The Second Affiliated Hospital of Zhengzhou Univesity,2013.
    [29]
    Bromberg JF,Wrzeszczynska MH,Devgan Q,et al.Stat3 as an oncogene[J].Cell,1999,98(3):295-303.
    [30]
    Nilsson CL,Dillon AR,Devakumar AA,et al.Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1r signaling network:an initial study in GSC11 glioblastoma stem cells[J].J Proteome Res,2010,9(1):430-443.
    [31]
    Liu XJ,Li J.A study of STAT3 and its relationship with pancreatic cancer[J].Liaoning Med Univ(辽宁医学院学报),2013,34(6):87-91.
    [32]
    Li DH,Xie KP,Wolff R,et al.Pancreatic cancer[J].Lancet,2004,363(9414):1049-1057.
    [33]
    Hutzen B,Willis W,Jones S,et al.Dietary agent,benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cell[J].Cancer Cell Int,2009,9:24.
    [34]
    Lu HF,Ma BQ,Zhang S,et al.Expression and clinical significance of STAT3,HIF-1α and VEGF in pancreatic carcinoma[J].Med J Qilu(齐鲁医学杂志),2014,29(3):196-201.
    [35]
    Debnath B,Xu S,Neamati N.Small molecule inhibitors of signal transducer and activator of transcription 3(Stat3)protein[J].J Med Chem,2012, 55(15):6645-6668.
    [36]
    Hou JJ,Sun BC.STAT3:The key player in the network of inflammation and cancer[J].Prog Biochem Biophys(生物化学与生物物理进展),2014,41(1):69-78.
    [37]
    Lee H,Herrmann A,Deng JH,et al.Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors[J].Cancer Cell,2009,15(4):283-293.
    [38]
    He G, Karin M. NF-kappaB and STAT3-key players in liver inflammation and cancer[J].Cell Res,2011,21(1):159-168.
    [39]
    Jie Y,Zhang F,Niu RF.Multiple regulation pathways and pivotal biological functions of STAT3 in cancer[J].Scientific Reports,2015,5:17663.
    [40]
    Zhu BR,Yang WW.Progress in the study of relationship between STAT3 and tumor immune escape[J].Chin J Clinicians(中华临床医师杂志),2013,7(22):10220-10222.
    [41]
    Krause A,Scaletta N,Ji JD,et al.Rheumatoid arthritis synoviocyte survival is dependent on Stat3[J].J Immunol,2002,169(11):6610-6616.
    [42]
    Wolk K,Witte E,Wallace E,et al.IL-22 regulates the expression of genes responsible for antimicrobial defense,cellular differentiation,and mobility in keratinocytes:a potential role in psoriasis[J].Eur J Immunol,2006,36(5):1309-1323.
    [43]
    Boniface K,Bernard FX,Garcia M,et al.IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes[J].J Immunol,2005,174(6):3695-3702.
    [44]
    Tokumaru S,Sayama K,Shirakata Y,et al.Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37[J].J Immunol,2005,175(7):4662-4668.
    [45]
    Miyoshi1 K,Takaishi M,Nakajima K,et al.Stat3 as a Therapeutic target for the treatment of psoriasis:a clinical feasibility study with STA-21,a Stat3 inhibitor[J].J Invest Dermatol,2011,131(1):108-117.
    [46]
    Hattori R,Maulik N,Otani H,et al.Role of STAT3 in ischemic preconditioning[J].J Mol Cell Cardiol,2001,33(11):1929-1936.
    [47]
    Maulik N,Sasaki H,Addya S,et al.Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors[J].FEBS Lett,2000,485(1):7-12.
    [48]
    Boengler K,Hilfiker-Kleiner D,Drexler H,et al.The myocardial JAK/STAT pathway:from protection to failure[J].Pharmacol Ther,2008,120(2):172-185.
    [49]
    Knight D,Mutsaers SE,Prêle CM.STAT3 in tissue fibrosis:is there a role in the lung[J] ? Pulm Pharmacol Ther,2011,24(2):193-198.
    [50]
    Ogata H,Chinen T,Yoshida T,et al.Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production[J].Oncogene,2006,25(17):2520-2530.
    [51]
    Lim CP,Phan TT,Lim IJ,et al.STAT3 contributes to keloid pathogenesis via promoting collagen production,cell proliferation and migration[J].Oncogene,2006,25(39):5416-5425.
    [52]
    Ki SH,Park1 O,Zheng M,et al.Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding:role of STAT3[J].Hepatology,2010,52(4):1291-1300.
    [53]
    Mashili F,Chibalin AV,Krook A,et al.Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes[J].Diabetes,2013,62(2):457-465.
    [54]
    Gao Q,Wolfqang MJ,Neschen S,et al.Disruption of neural signal transducer and activator of transcription 3 causes obesity,diabetes,infertility,and thermal dysregulation[J].Proc Natl Acad Sci U S A,2004,101(13):4661-4666.
    [55]
    Song H,Wang R,Wang S,et al.A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells[J].Proc Natl Acad Sci U S A,2005,102(13):4700-4705.
    [56]
    Li HM,Liu AG,Zhao ZJ,et al.Fragmentbased drug design and drug repositioning using multiple ligand simultaneous docking(MLSD):identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3(STAT3)[J].J Med Chem,2011,54(15):5592-5596.
    [57]
    Schust J,Sperl B,Hollis A,et al.Stattic:a small-molecule inhibitor of STAT3 activation and dimerization[J].Chem Biol,2006,13(11):1235-1242.
    [58]
    Siddiquee K,Zhang S,Guida WC,et al.Selective chemical probe inhibitor of Stat3,identified through structure-based virtual screening,induces antitumor activity[J].Proc Natl Acad Sci U S A,2007,104(18):7391-7396.
    [59]
    Page BD,Croucher DC,Li ZH,et al.Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal,small molecule Src homology 2 domain binders:promising agents against multiple myeloma[J].J Med Chem,2013,56(18):7190-7200.
    [60]
    Hao W,Hu Y,Niu C,et al.Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening[J].Bioorg Med Chem Lett,2008,18(18):4988-4992.
    [61]
    Matsuno K, Masuda Y, Uehara Y, et al. Identification of a new series of STAT3 inhibitors by virtual screening[J].ACS Med Chem Lett,2010,1(8):371-375.
    • Related Articles

  • Related Articles

    [1]CHEN Yanqing, GONG Ping, LIU Zhen, ZHANG Yan, YU Yang. Serum amyloid A 3 deficiency improves cognitive impairment and attenuates tau pathology in mouse model of Alzheimer′s disease[J]. Journal of China Pharmaceutical University, 2021, 52(5): 586-595. DOI: 10.11665/j.issn.1000-5048.20210511
    [2]YU Haiyang, CHEN Song, XU Zheng, GAO Xiangdong, YAO Wenbing. Protective effect of fibroin peptides on Aβ25-35-induced injury in SH-SY5Y cells and its mechanism[J]. Journal of China Pharmaceutical University, 2017, 48(5): 609-613. DOI: 10.11665/j.issn.1000-5048.20170517
    [3]LI Jing, JIN Xiaoting, ZHANG Liying. Synthesis and biological evaluation of novel amide derivatives of pentacyclic triterterpenes as inhibitors of glycogen phosphorylase[J]. Journal of China Pharmaceutical University, 2016, 47(4): 422-428. DOI: 10.11665/j.issn.1000-5048.20160406
    [4]WU Weixin, YAN Jia, TAN Xiying, LI Bo, SU Mengxiang, YAN Fang, DI Bin. Advances in enrichment strategies for phosphoproteomics and its application in the research of disease[J]. Journal of China Pharmaceutical University, 2016, 47(1): 19-29. DOI: 10.11665/j.issn.1000-5048.20160103
    [5]Cloning，over-expression and in vitro activity of aminoglycoside phosphotransferase from clinical MRSA isolates[J]. Journal of China Pharmaceutical University, 2010, 41(1): 81-85.
    [6]WEN Xiao-an, ZHANG Ying-xia, LIU Jun, ZHANG Lu-yong, NI Pei-zhou, SUN Hong-bin. Synthesis and biological activity of heterocycle-fused derivatives of pentacylic triterpenes as glycogen phosphorylase inhibitors[J]. Journal of China Pharmaceutical University, 2009, 40(6): 491-496.
    [7]SHI Wei, SUN Li, LIN Sen-sen, YUAN Sheng-tao, ZHANG Lu-yong. Construction of eukaryotic expression plasmid for human TF full-length，TF truncated and characterization of their biological function[J]. Journal of China Pharmaceutical University, 2009, 40(5): 465-470.
    [10]Studies on the Culture Conditions of E. aerogenes Mutant EAM-Z1 and its Phosphorylase Activity[J]. Journal of China Pharmaceutical University, 2003, (2): 85-87.

Catalog

    Get Citation
    PDF
    XML
    Article views (908) PDF downloads (1741) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：290234

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return